These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21098089)

  • 1. How good are current approaches to nonclinical evaluation of abuse and dependence?
    Moser P; Wolinsky T; Duxon M; Porsolt RD
    J Pharmacol Exp Ther; 2011 Mar; 336(3):588-95. PubMed ID: 21098089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current approaches and issues in non-clinical evaluation of abuse and dependence.
    Moser P; Wolinsky T; Castagné V; Duxon M
    J Pharmacol Toxicol Methods; 2011; 63(2):160-7. PubMed ID: 20868759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abuse liability assessment in preclinical drug development: predictivity of a translational approach for abuse liability testing using methylphenidate in four standardized preclinical study models.
    Teuns GB; Geys HM; Geuens SM; Stinissen P; Meert TF
    J Pharmacol Toxicol Methods; 2014; 70(3):295-309. PubMed ID: 24632211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Addictive potential in man: methodological aspects].
    Warot D; Marra D
    Therapie; 1995; 50(6):531-6. PubMed ID: 8745952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriate experimental approaches for predicting abuse potential and addictive qualities in preclinical drug discovery.
    Mead AN
    Expert Opin Drug Discov; 2014 Nov; 9(11):1281-91. PubMed ID: 25176123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction.
    Niwa M; Yan Y; Nabeshima T
    Ann N Y Acad Sci; 2008 Oct; 1141():76-95. PubMed ID: 18991952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive validity of the rat self-administration model for abuse liability.
    O'Connor EC; Chapman K; Butler P; Mead AN
    Neurosci Biobehav Rev; 2011 Jan; 35(3):912-38. PubMed ID: 21036191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse model of relapse to the abuse of drugs: procedural considerations and characterizations.
    Yan Y; Nabeshima T
    Behav Brain Res; 2009 Jan; 196(1):1-10. PubMed ID: 18782591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proactive nonclinical drug abuse and dependence liability assessment strategy: a sponsor perspective.
    Swedberg MD
    Behav Pharmacol; 2013 Sep; 24(5-6):396-402. PubMed ID: 23907375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are clinical impressions of adolescent substance use accurate?
    Wilson CR; Sherritt L; Gates E; Knight JR
    Pediatrics; 2004 Nov; 114(5):e536-40. PubMed ID: 15520086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug addiction research using intravenous self-administration procedure in mice].
    Koseki T; Nabeshima T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Jun; 45(3):147-56. PubMed ID: 20681247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychiatric disorders induced by drug dependence other than alcohol].
    Lejoyeux M; Mourad I; Ades J
    Encephale; 2000; 26(2):21-7. PubMed ID: 10858911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology of mood-altering drugs of abuse.
    Carr LA
    Prim Care; 1993 Mar; 20(1):19-31. PubMed ID: 8464940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug dependence study of the new cognition-enhancing agent nefiracetam in rats.
    Fujikawa K; Akiyama Y; Takayama S
    Arzneimittelforschung; 1994 Feb; 44(2A):243-7. PubMed ID: 8018097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous drug self-administration in mice: practical considerations.
    Thomsen M; Caine SB
    Behav Genet; 2007 Jan; 37(1):101-18. PubMed ID: 17226102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How does stress increase risk of drug abuse and relapse?
    Sinha R
    Psychopharmacology (Berl); 2001 Dec; 158(4):343-59. PubMed ID: 11797055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of drug dependence in animal experiments].
    Hoffmeister F
    Arzneimittelforschung; 1981; Suppl 27():53-8. PubMed ID: 7197940
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse.
    Swedberg MD
    J Pharmacol Toxicol Methods; 2016; 81():295-305. PubMed ID: 27235786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue?
    Budney AJ
    Addiction; 2006 Sep; 101 Suppl 1():125-33. PubMed ID: 16930169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.